ISO-1-3 Mutational status in the PI3K/AKT pathway and efficacy of mTOR inhibitors alone or combined with chemotherapeutics in ovarian clear cell carcinoma cells(Group 1 Oncology 1,IS Award Candidate,International Session)
mag（2013）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要